Altered ovarian function and cardiovascular risk factors in valproate-treated women
- 1 September 2001
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 111 (4) , 290-296
- https://doi.org/10.1016/s0002-9343(01)00806-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsyAnnals of Neurology, 1999
- Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2 052 922 and age-specific fertility rates of women with epilepsyPublished by Elsevier ,1998
- Drug treatment of mania: a critical reviewActa Psychiatrica Scandinavica, 1998
- Valproate, lamotrigine, and insulin‐mediated risks in women with epilepsyAnnals of Neurology, 1998
- Divalproex Sodium in Migraine ProphylaxisCephalalgia, 1997
- Obesity and endocrine disorders in women taking valproate for epilepsyAnnals of Neurology, 1996
- Valproic AcidDrugs, 1994
- Polycystic Ovaries and Hyperandrogenism in Women Taking Valproate for EpilepsyNew England Journal of Medicine, 1993
- A Comparison of Valproate with Carbamazepine for the Treatment of Complex Partial Seizures and Secondarily Generalized Tonic–Clonic Seizures in AdultsNew England Journal of Medicine, 1992
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989